XW043B3
Introduction of Cytarabine and Daunorubicin Liposome Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 3
| Pos | Category | Selected Element & Definition |
|---|---|---|
| X | Section |
New Technology
|
| W | Body System |
Anatomical Regions
|
| 0 | Operation |
Introduction
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
|
| 4 | Body System / Region |
Central Vein
|
| 3 | Approach |
Percutaneous
|
| B | Device / Substance / Technology |
Orca-T Allogeneic T-cell Immunotherapy
|
| 3 | Qualifier |
New Technology Group 3
|